Replimune Group's stock dropped about 84% between October 2025 and April 2026 after the FDA rejected its RP1 biologics license application due to unresolved study design concerns. Despite company statements suggesting progress toward approval, the FDA's complete response letter in April 2026 revealed that critical issues remained unaddressed, causing a sharp decline in share price. A securities class action lawsuit has been filed alleging the company misled investors about the drug's regulatory status. Investors who bought shares during this period may seek compensation by October 5, 2026.
Replimune Group's stock faced a severe decline of about 84% between October 2025 and April 2026 following regulatory setbacks. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: out of 91 priced US health-sector stocks, 59 rose and 31 fell. Notable movers include Recursion Pharmaceuticals Inc (RXRX) with a price of USD 3.37 and a 1-day change of +5.64%, Illumina, Inc. (ILMN) at USD 241.64 with a 1-day change of +5.55%, and Ginkgo Bioworks Holdings Inc (DNA) at USD 7.44 with a 1-day change of +5.38%.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
